Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT

Ngā tūemi rite

• Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT
  mā: Joanna Drozd-Sokolowska, me ētahi atu.
  I whakaputaina: (2026-04-01)
• Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
  mā: Dai Chihara, me ētahi atu.
  I whakaputaina: (2022-12-01)
• An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA
  mā: Kai Rejeski, me ētahi atu.
  I whakaputaina: (2023-05-01)
• Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group
  mā: Tobias Alexander, MD, me ētahi atu.
  I whakaputaina: (2024-08-01)
• Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
  mā: Laurent Garderet, me ētahi atu.
  I whakaputaina: (2024-03-01)